Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daichi Fujimoto

Showing results (41-50 of 165) with videos related to

Pageof 17
Sort By:
Lung Cancer (Amsterdam, Netherlands)|April 28, 2019
Clinical significance of monitoring EGFR mutation in plasma using multiplexed digital PCR in EGFR mutated patients treated with afatinib (West Japan Oncology Group 8114LTR study)Hiroaki Akamatsu, Yasuhiro Koh, Isamu Okamoto, et al.
Molecular and Clinical Oncology|March 24, 2015
Response to bevacizumab combination chemotherapy of malignant pleural effusions associated with non-squamous non-small-cell lung cancerKatsuhiro Masago, Daichi Fujimoto, Shiro Fujita, et al.
Lung Cancer (Amsterdam, Netherlands)|June 12, 2019
Nivolumab for advanced non-small cell lung cancer patients with mild idiopathic interstitial pneumonia: A multicenter, open-label single-arm phase II trialDaichi Fujimoto, Makiko Yomota, Akimasa Sekine, et al.
Clinical Lung Cancer|September 11, 2018
Osimertinib With Ramucirumab in EGFR-mutated, T790M-positive Patients With Progression During EGFR-TKI Therapy: Phase Ib StudyHiroaki Akamatsu, Yasuhiro Koh, Yuichi Ozawa, et al.
Cancer Chemotherapy and Pharmacology|December 13, 2017
Concordance between the response evaluation criteria in solid tumors version 1.1 and the immune-related response criteria in patients with non-small cell lung cancer treated with nivolumab: a multicenter retrospective cohort studyYuki Kataoka, Katsuya Hirano, Tomoko Narabayashi, et al.
Anticancer Research|December 27, 2017
Carcinoembryonic Antigen as a Predictive Biomarker of Response to Nivolumab in Non-small Cell Lung CancerYuki Kataoka, Katsuya Hirano, Tomoko Narabayashi, et al.
Respiratory Care|June 25, 2015
Efficacy of High-Flow Nasal Cannula Therapy in Acute Hypoxemic Respiratory Failure: Decreased Use of Mechanical VentilationKazuma Nagata, Takeshi Morimoto, Daichi Fujimoto, et al.
Medical Oncology (Northwood, London, England)|April 12, 2012
Association between vascular-poor area of primary tumors and epidermal growth factor receptor gene status in advanced lung adenocarcinomaYosuke Togashi, Katsuhiro Masago, Takeshi Kubo, et al.
Internal Medicine (Tokyo, Japan)|June 28, 2019
Elevated Adenosine Deaminase Levels in the Cerebrospinal Fluid in Immune Checkpoint Inhibitor-induced Autoimmune EncephalitisSatoru Fujiwara, Naoya Mimura, Hajime Yoshimura, et al.
Respirology (Carlton, Vic.)|June 14, 2017
Natural history and clinical characteristics of multiple pulmonary nodules with ground glass opacityYuki Sato, Daichi Fujimoto, Takeshi Morimoto, et al.
Pageof 17

Showing results (41-50 of 165) with videos related to

Sort By:
Pageof 17
Lung Cancer (Amsterdam, Netherlands)|April 28, 2019
Clinical significance of monitoring EGFR mutation in plasma using multiplexed digital PCR in EGFR mutated patients treated with afatinib (West Japan Oncology Group 8114LTR study)Hiroaki Akamatsu, Yasuhiro Koh, Isamu Okamoto, et al.
Molecular and Clinical Oncology|March 24, 2015
Response to bevacizumab combination chemotherapy of malignant pleural effusions associated with non-squamous non-small-cell lung cancerKatsuhiro Masago, Daichi Fujimoto, Shiro Fujita, et al.
Lung Cancer (Amsterdam, Netherlands)|June 12, 2019
Nivolumab for advanced non-small cell lung cancer patients with mild idiopathic interstitial pneumonia: A multicenter, open-label single-arm phase II trialDaichi Fujimoto, Makiko Yomota, Akimasa Sekine, et al.
Clinical Lung Cancer|September 11, 2018
Osimertinib With Ramucirumab in EGFR-mutated, T790M-positive Patients With Progression During EGFR-TKI Therapy: Phase Ib StudyHiroaki Akamatsu, Yasuhiro Koh, Yuichi Ozawa, et al.
Cancer Chemotherapy and Pharmacology|December 13, 2017
Concordance between the response evaluation criteria in solid tumors version 1.1 and the immune-related response criteria in patients with non-small cell lung cancer treated with nivolumab: a multicenter retrospective cohort studyYuki Kataoka, Katsuya Hirano, Tomoko Narabayashi, et al.
Anticancer Research|December 27, 2017
Carcinoembryonic Antigen as a Predictive Biomarker of Response to Nivolumab in Non-small Cell Lung CancerYuki Kataoka, Katsuya Hirano, Tomoko Narabayashi, et al.
Respiratory Care|June 25, 2015
Efficacy of High-Flow Nasal Cannula Therapy in Acute Hypoxemic Respiratory Failure: Decreased Use of Mechanical VentilationKazuma Nagata, Takeshi Morimoto, Daichi Fujimoto, et al.
Medical Oncology (Northwood, London, England)|April 12, 2012
Association between vascular-poor area of primary tumors and epidermal growth factor receptor gene status in advanced lung adenocarcinomaYosuke Togashi, Katsuhiro Masago, Takeshi Kubo, et al.
Internal Medicine (Tokyo, Japan)|June 28, 2019
Elevated Adenosine Deaminase Levels in the Cerebrospinal Fluid in Immune Checkpoint Inhibitor-induced Autoimmune EncephalitisSatoru Fujiwara, Naoya Mimura, Hajime Yoshimura, et al.
Respirology (Carlton, Vic.)|June 14, 2017
Natural history and clinical characteristics of multiple pulmonary nodules with ground glass opacityYuki Sato, Daichi Fujimoto, Takeshi Morimoto, et al.
Pageof 17